Dow Inc. (NYSE:DOW) is reportedly considering selling its 35% stake in Sadara Chemical, its $20 billion chemicals joint venture with Saudi Aramco, as the company continues to reshape its portfolio amid a prolonged downturn in the global chemicals industry. No final decision has been made, and Aramco or another strategic or financial investor could potentially acquire Dow’s stake.
The potential exit comes as Sadara has become a significant financial burden for Dow. As of June 30, Dow Inc. had a negative investment balance of $793 million in Sadara and had suspended recognition of its share of the venture’s equity losses in the first quarter. Dow has also been exposed to Sadara’s financing obligations and previously disclosed that the venture had drawn on a credit facility.
At the same time, Sadara remains a major industrial asset, operating a complex in Jubail with more than 3 million metric tons of annual chemicals and plastics capacity. Its operations were disrupted earlier this year by the Middle East conflict, adding transportation, supply-chain, and operating pressures to an industry already dealing with weak demand and global oversupply.
Shedding Sadara Could Reduce Financial Pressure on Dow
The strongest argument for Dow Inc. is that exiting Sadara could remove a persistent drag on cash flow and allow management to redirect capital toward businesses with better returns. Dow’s exposure to Sadara is no longer simply an investment in a large Saudi chemicals complex; the company has accumulated a negative investment balance and financial obligations associated with the venture. A sale could therefore reduce Dow’s exposure to future funding requirements and limit the amount of capital that could otherwise have to be committed to the partnership.
That would be particularly valuable because Dow is already trying to improve its cash generation. Management has said its objective is to reach free-cash-flow breakeven while pursuing significant cost reductions. In March, CEO Jim Fitterling said Dow’s goal was to avoid putting additional cash into Sadara during 2026, while describing the venture as having low operating cash costs but more challenging fixed costs and financing obligations.
An exit would also strengthen the logic behind Dow Inc.’s broader portfolio restructuring. The company has been reviewing assets and cutting costs to concentrate resources on operations that can generate stronger returns. Selling a non-core or financially burdensome investment would give management another opportunity to simplify the portfolio and potentially improve returns on invested capital.
The biggest upside, therefore, may not come from the sale proceeds themselves. It could come from eliminating future financial commitments and reducing the uncertainty surrounding Sadara. If Aramco is willing to acquire Dow’s stake at an attractive valuation, Dow could simultaneously raise cash, reduce its exposure to Sadara, and improve its financial flexibility. Aramco’s existing 65% ownership also makes it a natural potential buyer.
From an investor perspective, this could make Dow easier to value. Rather than waiting for Sadara’s profitability and balance-sheet issues to improve, investors could begin focusing more heavily on Dow’s core portfolio and whether its cost-cutting and restructuring initiatives can restore earnings and free cash flow.
Dow Could Give Up Long-Term Upside for Short-Term Relief
The biggest concern is that Dow Inc. could be selling a strategically important asset at an unfavorable point in the chemicals cycle. The industry is suffering from weak demand, persistent global oversupply, and elevated production costs, while geopolitical disruptions have added another layer of uncertainty. Those conditions could depress the value of Sadara and leave Dow with limited negotiating power if it tries to sell its stake now.
There is also a risk that the transaction provides less financial relief than the headline $20 billion investment figure suggests. The $20 billion represents the original scale of the joint venture, not the current market value of Dow’s 35% stake. Given Sadara’s negative investment balance and financing obligations, Dow could potentially have to accept a relatively modest valuation or make other financial concessions to complete an exit.
More importantly, Dow Inc. could be giving up meaningful upside if the global chemicals market eventually recovers. Sadara is a large, integrated facility with substantial production capacity, and Saudi Arabia offers advantages in feedstock availability and integration with Aramco’s broader hydrocarbons business. If chemical margins improve, Dow would no longer participate in that recovery. The company would essentially be trading future potential upside for greater financial certainty today.
Finally, the market could interpret an exit as evidence that Dow is struggling to generate adequate returns from some of its major investments. If the company sells Sadara at a low valuation while continuing to face weak earnings and cash-flow conditions elsewhere, investors may view the transaction as defensive rather than transformational.
Conclusion
Dow Inc.’s potential exit from Sadara could be positive for its financial flexibility by reducing future funding needs and allowing greater focus on higher-return businesses. However, selling during a weak chemicals cycle could limit the value realized and cause Dow to miss a future recovery. Overall, the move is cautiously bullish if Dow can secure favorable terms and meaningfully reduce its financial exposure.
READ NEXT: Chime Financial (CHYM) Moves Deeper into Banking with $590 Million Stride Acquisition and Smithfield Foods (SFD) Warns of Fresh Pork Loss as Industry Spreads Compress
This article is originally published at Insider Monkey.
Hedge Fund Resource Center